Comprehensive analysis of global SYNGAP1 patient distribution trends, growth patterns, and regional insights from 2020 to 2025.
The current patient count represents only the tip of the iceberg. Significant growth is imminent due to several accelerating factors:
Many patients remain undiagnosed or unreported. As awareness spreads and testing becomes more accessible, we anticipate a substantial increase in documented cases worldwide.
Patient count by country as of Q2 2025
Distribution by region
Countries with highest growth rates
Patient distribution across continents over time
Growth by continent
Quarterly new patient additions
Time for countries to double patient count
Statistical models for future patient growth
Data-driven recommendations